Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Certican vs MMF with Neoral in de novo heart transplant recipients
2004-001052-36Phase 3Completed
- Sponsor
- Novartis
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of everolimus in Cardiac Rejection, sponsored by Novartis. Started Apr 2005; status: completed.
02
Drugs
everolimus
03
Conditions
Cardiac Rejection
Beyond the preview
Go deeper on 2004-001052-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001052-36.